Lightcast Discovery
2 known investors
Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale. The platform serves researchers and therapeutics developers studying functional biology for applications in antibody discovery, cellular therapies, and immunotherapy development.
BiotechDeep TechMedical Devices
Investors · 2
In the news
- Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platformbusinesswire.com · 2026
- Lightcast Announces Limited Commercial Release of Envisia™ Single-Cell Functional Analysis Platform for Antibody Discoverybusinesswire.com · 2025
- Lightcast Discovery - 2025 Company Profile, Team, Funding, Competitors & Financials - Tracxntracxn.com · 2023
- Lightcast Discovery - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2023
- Empowering research: Lightcast Discovery secures $49M to unveil Single-Cell functional analysis platform — TFNtechfundingnews.com · 2023
- Lightcast Discovery Raises $49M in Series B Financingfinsmes.com · 2023